Please select a schedule to view:

• Schedule At-A-Glance
• Preliminary Agenda

	Schedule At-A-Glance
	Saturday, April 29, 2000			Sunday, April 30, 2000			Monday, May 1, 2000			Tuesday, May 2, 2000
			7:00	Registration		7:00	Poster Set-Up and Registration		7:00	Registration
						7:30	Continential Breakfast		7:30	Continential Breakfast
						8:00	Symposium 3: Immunologic Responses at the Extremes of Life		8:00	Symposium 5: Vaccines for Sexually Transmitted Diseases
			8:30	Continential Breakfast
			9:00	Welcome and Introductions
			9:10	Keynote Address
			9:45	Mary Lou Clements-Mann Memorial Lecture
						10:00	Coffee Break/Poster Session		10:00	Coffee Break
			10:30	Coffee Break		10:30	Submitted Presentations 3 & 4		10:30	Symposium 6: Innate Immunity / Submitted Presentations 7
			11:00	Symposium 1: The Economics of Vaccines: Industry-Public Health Interface
			12:00	Lunch		12:00	Lunch		12:00	Lunch
									1:15	Symposium 7: Genomics and Vaccinology
			1:30	Submitted Presentations 1 & 2		1:30	Submitted Presentations 5 & 6
			3:00	Coffee Break		3:00	Coffee Break
									3:10	Coffee Break
			3:30	Symposium 2: Global Control & Eradication of Diseases Using Methods Currently Available		3:30	Symposium 4: Respiratory Vaccines on the Near Horizon		3:30	Symposium 8: Controversies in Vaccine Safety
									5:00	Participant Evaluation
									5:10	Adjournment
			5:30	Adjournment		5:30	Poster Session and Reception
			6:00	Opening Reception
7:00	Registration (until 9:00 p.m.)		7:00	Presentation of the Albert B. Sabin Gold Medal
						7:30	Adjournment and Poster Removal

7:00 - 9:00 p.m. Registration

7:00 - 9:00 a.m.

Registration

8:30 a.m.

Continental Breakfast

9:00 a.m.

Welcome and Introductions

Keynote Address

9:10 a.m.

Keynote Address William H. Foege, M.D. Emory University

9:40 a.m.

Questions and Answers

Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences

9:45 a.m.

The Promise of 21st Century Science: Goals for the Global Alliance for Vaccines and Immunization Sir Gustav Nossal University of Melbourne

10:25 a.m.

Questions and Answers

10:30 a.m.

Coffee Break

Symposium 1: The Economics of Vaccines: Industry-Public Health Interface

11:00 a.m.

The World Bank Perspective Amie E. Batson, M.B.A. The World Bank

11:25 a.m.

Questions and Answers

11:30 a.m.

The Industry Perspective Michel De Wilde, Ph.D. Pasteur Mérieux Connaught

11:55 a.m.

Questions and Answers

12:00 p.m.

Lunch

Submitted Presentations 1 (Concurrent Session)

1:30 p.m.

Submitted Presentations 1

3:00 p.m.

Coffee Break

Submitted Presentations 2 (Concurrent Session)

1:30 p.m.

Submitted Presentations 2

3:00 p.m.

Coffee Break

Symposium 2: Global Control and Eradication of Diseases Using Tools Currently Available

3:30 p.m.

Status Report on the Global Initiative to Eradicate Polio Bruce Aylward, M.D. World Health Organization

4:00 a.m.

Questions and Answers

4:10 p.m.

Is a Global Initiative to Eradicate Measles Epidemiologically and Logistically Feasible? Ciro de Quadros, M.D. Pan American Health Organization

4:40 a.m.

Questions and Answers

4:50 p.m.

Efforts to Control Invasive Disease Caused by Haemophilus influenzae type B: A Global View Joel I. Ward, M.D. Harbor-UCLA Medical Center UCLA Center for Vaccine Research

5:20 a.m.

Questions and Answers

5:30 p.m.

Adjournment

6:00 p.m.

Opening Reception

7:00 p.m.

Presentation of the Albert B. Sabin Gold Medal

7:00 a.m. - 8:00 a.m.	Registration and Continental Breakfast
Symposium 5: Vaccines for Sexually Transmitted Infections
8:00 a.m.	Mucosal Immunization for Sexually Transmitted Infections Jerry R. McGhee, Ph.D. University of Alabama at Birmingham
8:20 a.m.	Questions and Answers
8:30 a.m.	Vaccines for Genital Herpesvirus Infections Lawrence Corey, M.D. University of Washington Fred Hutchinson Cancer Research Center
8:50 a.m.	Questions and Answers
9:00 a.m.	Current Status of Chlamydia Vaccines Richard S. Stephens, Ph.D. University of California, Berkeley
9:20 a.m.	Questions and Answers
9:30 a.m.	Human Papillomavirus Vaccines John T. Schiller, Ph.D. National Cancer Institute
9:55 a.m.	Questions and Answers
10:00 a.m.	Coffee Break
Symposium 6: Innate Immunity (Concurrent Session)
10:30 a.m.	Innate Immunity Overview Peter L. Nara, D.V.M., Ph.D. Biological Mimetics, Inc. International Society for Vaccines
11:00 a.m.	Questions and Answers
11:30 a.m.	Pattern Recognition and Innate Immunity R. Alan B. Ezekowitz, D.Phil., M.B.Ch.B. Massachusetts General Hospital Harvard Medical Center
11:30 a.m.	Discussion
12:00 a.m.	Lunch
	Submitted Presentations 7 (Concurrent Session)
10:30 a.m.	Submitted Presentations 7
12:00 p.m.	Lunch
Symposium 7: Genomics and Vaccinology
1:15 p.m.	Introduction Michael Gottlieb, Ph.D. National Institute of Allergy and Infectious Diseases
1:25 p.m.	Bioinformatics and Predictive Algorithms Anne S. DeGroot, M.D. Brown University EpiVax, Inc.
1:45 p.m.	Questions and Answers
1:55 p.m.	High Throughput Screening and Pooled Genomic Sequences Stephen A. Johnston, Ph.D. University of Texas Southwestern Medical Center
2:15 p.m.	Questions and Answers
2:25 p.m.	Point-Counterpoint: A Pragmatic View of Vaccine R & D John B. Robbins, M.D. National Institute of Child Health and Human Development
2:55 p.m.	Panel Discussion
3:10 p.m.	Coffee Break
Symposium 8: Controversies in Vaccine Safety
3:30 p.m.	Preservatives: Friends or Foes? William M. Egan, Ph.D. Food and Drug Administration
3:50 p.m.	Questions and Answers
4:00 p.m.	Is There a Relationship Between Vaccines and Autoimmune Disease? Charles A. Janeway, Jr., M.D. Yale University School of Medicine Howard Hughes Medical Institute
4:20 p.m.	Questions and Answers
4:30 p.m.	New Cell Substrates: Challenges and Promises John Petricciani, M.D. International Association for Biologicals
4:50 p.m.	Questions and Answers
5:00 p.m.	Participant Evaluation
5:10 p.m.	Adjournment

• Back to NFID-SPONSORED CONFERENCES